“[Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]” (2017) Farmeconomia. Health Economics and Therapeutic Pathways, 18(2S). doi:10.7175/fe.v18i2s.1320.